ALDX
Aldeyra Therapeutics, Inc.
+0.03 (+2.55%)1.41USD176K成交股數84.8M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.5M | 2.4M | 4.3M | 5.4M | 8.5M | 7.4M | 12.4M | 15.0M | 6.2M | 4.3M | 7.0M | 7.0M |
| 銷售管理費用 | 2.4M | 1.1M | 2.4M | 2.6M | 1.7M | 3.0M | 3.7M | 3.0M | 3.2M | 1.8M | 2.6M | 3.4M |
| 營業利益 | −5.9M-42% | −3.5M-66% | −6.7M-59% | −8.0M-56% | −10.2M+8% | −10.4M+71% | −16.1M+69% | −18.0M+74% | −9.4M | −6.1M | −9.6M | −10.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −5.5M-44% | −3.5M-65% | −6.5M-57% | −7.7M-54% | −9.8M+21% | −9.9M+109% | −15.1M+85% | −16.8M+87% | −8.1M | −4.8M | −8.2M | −9.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.09-44% | -0.06-65% | -0.10-60% | -0.13-54% | -0.16+14% | -0.17+113% | -0.25+79% | -0.28+87% | -0.14 | -0.08 | -0.14 | -0.15 |
| 稀釋股數 | 60.3M | 60.3M | 60.1M | 60.1M | 60.0M | 59.9M | 59.5M | 59.4M | 59.4M | 58.9M | 59.0M | 58.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 45.1M | 65.0M | 70.0M | 59.3M | 41.2M | 50.4M | 68.1M | 71.0M | 102M | 143M | 143M | 152M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 47.5M | 66.5M | 72.1M | 77.8M | 85.0M | 93.2M | 117M | 126M | 141M | 148M | 147M | 156M |
| 有息負債 | – | 0.00 | 0.00 | 0.00 | 0.00 | 15.1M | 15.0M | 0.00 | 0.00 | 0.00 | 2.7M | 10.1M |
| 總負債 | 9.7M | 24.3M | 27.8M | 28.6M | 29.7M | 29.6M | 32.2M | 27.7M | 27.9M | 28.5M | 24.3M | 25.7M |
| 股東權益 | 37.9M | 42.2M | 44.3M | 49.2M | 55.3M | 63.6M | 85.1M | 98.3M | 113M | 120M | 123M | 130M |
| 負債比 | 20.3% | 36.6% | 38.6% | 36.7% | 34.9% | 31.8% | 27.5% | 22.0% | 19.7% | 19.2% | 16.5% | 16.5% |
| 淨現金(現金 − 有息負債) | – | 65.0M | 70.0M | 59.3M | 41.2M | 35.3M | 53.1M | 71.0M | 102M | 143M | 141M | 142M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.1M-59% | – | – | – | −12.5M | – | – | −10.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −33.8M | –% | -0.56 | – |
| FY2024 | – | – | −55.9M | –% | -0.94 | – |
| FY2023 | – | – | −37.5M | –% | -0.64 | −30.3M |
| FY2022 | – | – | −62.0M | –% | -1.06 | −56.7M |
| FY2021 | – | – | −57.8M | –% | -1.07 | −42.6M |
| FY2020 | – | – | −37.6M | –% | -1.11 | – |
| FY2019 | – | – | −60.8M | –% | -2.24 | −45.0M |
| FY2018 | – | – | −38.9M | –% | -1.79 | −30.1M |